Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart sensor aims to protect preemies from hidden metal in IV food

NCT ID NCT07646925

Knowledge-focused Sponsor: Han Tongyan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will develop a portable sensor to measure aluminum levels in the IV nutrition given to preterm babies. Researchers will collect samples from 250 infants to track aluminum exposure and see if it's linked to health problems like feeding issues or lung disease. The goal is to create a tool that helps doctors make IV nutrition safer for the tiniest patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could provide a new tool to monitor aluminum exposure in vulnerable infants, helping to reduce complications from IV nutrition.
What could go wrong
This is an early observational study focused on detection, not treatment. The sensor may not be accurate enough for clinical use, and results may not apply to all hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Preterm infants (\<37 weeks' gestation) receiving parenteral nutrition (PN) for ≥5 days in the NICU of Peking University Third Hospital will be enrolled. Infants with severe inborn errors of metabolism, major congenital malformations, early death, or incomplete data will be excluded.

Ages

0 days to 1 day

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Preterm infants receiving parenteral nutrition (PN) in the Neonatal Intensive Care Unit (NICU) of Peking University Third Hospital, with gestational age \<37 weeks, PN administered for ≥5 days, complete clinical records, and written informed consent from parents/legal guardians. Exclusion Criteria: * Infants with severe inborn errors of metabolism, major congenital malformations, early death, or incomplete data will be excluded.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Trace aluminum ions in parenteral nutrition are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Trace aluminum ions in parenteral nutrition

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.